myocardial infarction. Diseases of the circulatory system
Conditions
Interventions
Intervention 1: The Intervention group will receive 1 gram of Omega-3 capsules per day orally for 3 months. Intervention 2: The Control group will receive 1 gram of Placebo capsules per day orally for
Treatment - Drugs
The Intervention group will receive 1 gram of Omega-3 capsules per day orally for 3 months
The Control group will receive 1 gram of Placebo capsules per day orally for 3 months
Sponsors
Vice Chancellor for research of Gonabad University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion Criteria: patients with myocardial infarction accepted in ccu Exclusion Criteria: Patients with a history of liver disease, cardiogenic shock, heart failure and History of stroke within the last 6 months Will be excluded.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Liver injury. Timepoint: Admission every day and then a week, then a month or two later. Method of measurement: Measurement of ALT. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Moghimian
Gonabad University of Medical Sciences
Outcome results
None listed